Cargando…

Xuesaitong Combined with Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats by Activating Keap1/Nrf2 Signaling and Mitophagy in Hippocampal Tissue

Ischemic stroke is the most common type of cerebrovascular disease with high mortality and poor prognosis, and cerebral ischemia-reperfusion (CI/R) injury is the main murderer. Here, we attempted to explore the effects and mechanism of Xuesaitong (XST) combined with dexmedetomidine (Dex) on CI/R inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Guo-Jie, Min, Xiang-Zhen, Ma, Shuang-Shuang, Ding, Chuan, Wang, Xiu-Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750788/
https://www.ncbi.nlm.nih.gov/pubmed/36531207
http://dx.doi.org/10.1155/2022/5126042
_version_ 1784850334444683264
author Han, Guo-Jie
Min, Xiang-Zhen
Ma, Shuang-Shuang
Ding, Chuan
Wang, Xiu-Qin
author_facet Han, Guo-Jie
Min, Xiang-Zhen
Ma, Shuang-Shuang
Ding, Chuan
Wang, Xiu-Qin
author_sort Han, Guo-Jie
collection PubMed
description Ischemic stroke is the most common type of cerebrovascular disease with high mortality and poor prognosis, and cerebral ischemia-reperfusion (CI/R) injury is the main murderer. Here, we attempted to explore the effects and mechanism of Xuesaitong (XST) combined with dexmedetomidine (Dex) on CI/R injury in rats. First, a rat model of CI/R injury was constructed via the middle cerebral artery occlusion (MCAO) method and treated with XST and Dex alone or in combination. Then, on the 5th and 10th days of treatment, the neurological impairment was assessed using the modified neurological severity scores (mNSS), the 8-arm radial maze test (8ARMT), novel object recognition test (NORT), and fear conditioning test (FCT). H&E staining was performed to observe the pathological changes of the hippocampus. ELISA and related kits were used to assess the monoamine neurotransmitters and antioxidant enzyme activities in the hippocampus. The ATP, mitochondrial membrane potential levels, and qRT-PCR of genes related to mitochondrial function were determined to assess mitochondrial functions in the hippocampus and western blot to determine Keap1/Nrf2 signaling pathway and mitophagy-related protein expression. The results showed that XST combined with Dex significantly reduced mNSS, improved spatial memory and learning deficits, and enhanced fear memory and cognitive memory ability in CI/R rats, which was superior to single-drug treatment. Moreover, XST combined with Dex treatment improved hippocampal histopathological damage; significantly increased the levels of monoamine neurotransmitters, neurotrophic factors, ATP, and mitochondrial membrane potential; and upregulated the activities of antioxidant enzymes and the expression of mitophagy-related proteins in the hippocampus of CI/R rats. XST combined with Dex treatment also activated the Keap1/Nrf2 signaling and upregulated the protein expression of downstream antioxidant enzymes HO-1 and NQ. Altogether, this study showed that a combination of XST and Dex could activate the Keap1/Nrf2 signaling and mitophagy to protect rats from CI/R-related neurological impairment.
format Online
Article
Text
id pubmed-9750788
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-97507882022-12-15 Xuesaitong Combined with Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats by Activating Keap1/Nrf2 Signaling and Mitophagy in Hippocampal Tissue Han, Guo-Jie Min, Xiang-Zhen Ma, Shuang-Shuang Ding, Chuan Wang, Xiu-Qin Oxid Med Cell Longev Research Article Ischemic stroke is the most common type of cerebrovascular disease with high mortality and poor prognosis, and cerebral ischemia-reperfusion (CI/R) injury is the main murderer. Here, we attempted to explore the effects and mechanism of Xuesaitong (XST) combined with dexmedetomidine (Dex) on CI/R injury in rats. First, a rat model of CI/R injury was constructed via the middle cerebral artery occlusion (MCAO) method and treated with XST and Dex alone or in combination. Then, on the 5th and 10th days of treatment, the neurological impairment was assessed using the modified neurological severity scores (mNSS), the 8-arm radial maze test (8ARMT), novel object recognition test (NORT), and fear conditioning test (FCT). H&E staining was performed to observe the pathological changes of the hippocampus. ELISA and related kits were used to assess the monoamine neurotransmitters and antioxidant enzyme activities in the hippocampus. The ATP, mitochondrial membrane potential levels, and qRT-PCR of genes related to mitochondrial function were determined to assess mitochondrial functions in the hippocampus and western blot to determine Keap1/Nrf2 signaling pathway and mitophagy-related protein expression. The results showed that XST combined with Dex significantly reduced mNSS, improved spatial memory and learning deficits, and enhanced fear memory and cognitive memory ability in CI/R rats, which was superior to single-drug treatment. Moreover, XST combined with Dex treatment improved hippocampal histopathological damage; significantly increased the levels of monoamine neurotransmitters, neurotrophic factors, ATP, and mitochondrial membrane potential; and upregulated the activities of antioxidant enzymes and the expression of mitophagy-related proteins in the hippocampus of CI/R rats. XST combined with Dex treatment also activated the Keap1/Nrf2 signaling and upregulated the protein expression of downstream antioxidant enzymes HO-1 and NQ. Altogether, this study showed that a combination of XST and Dex could activate the Keap1/Nrf2 signaling and mitophagy to protect rats from CI/R-related neurological impairment. Hindawi 2022-12-07 /pmc/articles/PMC9750788/ /pubmed/36531207 http://dx.doi.org/10.1155/2022/5126042 Text en Copyright © 2022 Guo-Jie Han et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Han, Guo-Jie
Min, Xiang-Zhen
Ma, Shuang-Shuang
Ding, Chuan
Wang, Xiu-Qin
Xuesaitong Combined with Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats by Activating Keap1/Nrf2 Signaling and Mitophagy in Hippocampal Tissue
title Xuesaitong Combined with Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats by Activating Keap1/Nrf2 Signaling and Mitophagy in Hippocampal Tissue
title_full Xuesaitong Combined with Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats by Activating Keap1/Nrf2 Signaling and Mitophagy in Hippocampal Tissue
title_fullStr Xuesaitong Combined with Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats by Activating Keap1/Nrf2 Signaling and Mitophagy in Hippocampal Tissue
title_full_unstemmed Xuesaitong Combined with Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats by Activating Keap1/Nrf2 Signaling and Mitophagy in Hippocampal Tissue
title_short Xuesaitong Combined with Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats by Activating Keap1/Nrf2 Signaling and Mitophagy in Hippocampal Tissue
title_sort xuesaitong combined with dexmedetomidine improves cerebral ischemia-reperfusion injury in rats by activating keap1/nrf2 signaling and mitophagy in hippocampal tissue
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750788/
https://www.ncbi.nlm.nih.gov/pubmed/36531207
http://dx.doi.org/10.1155/2022/5126042
work_keys_str_mv AT hanguojie xuesaitongcombinedwithdexmedetomidineimprovescerebralischemiareperfusioninjuryinratsbyactivatingkeap1nrf2signalingandmitophagyinhippocampaltissue
AT minxiangzhen xuesaitongcombinedwithdexmedetomidineimprovescerebralischemiareperfusioninjuryinratsbyactivatingkeap1nrf2signalingandmitophagyinhippocampaltissue
AT mashuangshuang xuesaitongcombinedwithdexmedetomidineimprovescerebralischemiareperfusioninjuryinratsbyactivatingkeap1nrf2signalingandmitophagyinhippocampaltissue
AT dingchuan xuesaitongcombinedwithdexmedetomidineimprovescerebralischemiareperfusioninjuryinratsbyactivatingkeap1nrf2signalingandmitophagyinhippocampaltissue
AT wangxiuqin xuesaitongcombinedwithdexmedetomidineimprovescerebralischemiareperfusioninjuryinratsbyactivatingkeap1nrf2signalingandmitophagyinhippocampaltissue